跳至主要内容
临床试验/NCT03346655
NCT03346655进行中(未招募)不适用

Brain Metastases in Norway - Improved Classification and Treatment. A Prospective Cohort Study

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
3,000
试验地点
1
主要终点
Overall survival after diagnosis of brain metastases

研究概览

简要总结

The overall aim and primary outcome of this study will be a descriptive analysis of the current treatment practice of BM in Norway. Specifically, it may give answers to the following research questions:

  • What is the true incidence of BM in Norway?
  • How are patients with BM treated at present?
  • Do treatments differ between hospitals?
  • How do treatments impact quality of life of the patients?
  • Which factors (treatment, tumor and host variables) can explain disease control, survival, symptom relief, and general functions?
  • How can BM staging be improved?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Verified cancer diagnosis of solid tumors (based on radiological, histological/cytological or operative evidence).
  • •Brain metastases verified by computer tomography (CT), contrast-enhanced magnetic resonance imaging (MRI), or surgical biopsies
  • •Age ≥ 18 years
  • •Able to comply with study procedures
  • •Able to provide written informed consent after information in Norwegian

排除标准

  • •Primary brain tumors
  • •Primary hematological malignancies (lymphomas, leukemias)
  • •Previous diagnosis and/or treatment of BM
  • •Unable to produce written informed consent after information in Norwegian

结局指标

主要结局

Overall survival after diagnosis of brain metastases

时间窗: Time from diagnosis of brain metastases till death of any cause, assessed up to 12 months

Calculation of the overall survival times for each patient enrolled

次要结局

  • Treatment offered to patients diagnosed with brain metastases(3 years)
  • Changes in patient reported symptoms and quality of life items through EORTC questionnaire QLQ PAL15 and submodule BN20(Monthly up to 12 months after inclusion)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Olav Erich Yri

MD, PhD, Postdoctoral research fellow

Oslo University Hospital

研究点 (1)

Loading locations...

相似试验